JZ

Jerome Zacharias

Director Director DIN 01903026
DIN 01903026 First appointment Nov 2005 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 3 historical roles
Total affiliations 3 Since Nov 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Jerome Zacharias

Data last updated:

Jerome Zacharias was a Director at Regenix Drugs Limited (2007–2008), Director at Fascimed Pharmaceuticals Limited (from 2005) and Director at Gfin Capital Limited (from 2005). The companies operate in Healthcare.

DIN 01903026
Primary Designation Director
Industry Healthcare
First Appointment 01 Nov 2005
Oldest Company Age 27 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Regenix Drugs Limited U24232TN2007PLC063446
Director10 May 20072007₹188 Cr (FY 2024)Active
Fascimed Pharmaceuticals Limited U24231TN1999PLC042664
Director01 Nov 20051999Strike Off
Gfin Capital Limited U65993TN2003PLC050215
Director01 Nov 20052003Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fascimed Pharmaceuticals Limited
Gfin Capital Limited
Regenix Drugs Limited
Premium access

Shareholding and investment profile for Jerome Zacharias

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jerome Zacharias

Jerome Zacharias was first appointed on 01 Nov 2005 as Director at Fascimed Pharmaceuticals Limited. The most recent appointment on record is 10 May 2007 at Regenix Drugs Limited.

Jerome Zacharias held 3 earlier board appointments: Regenix Drugs Limited (Director, 10 May 2007 to 14 Jun 2008); Fascimed Pharmaceuticals Limited (Director, from 01 Nov 2005); Gfin Capital Limited (Director, from 01 Nov 2005).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available